A detailed history of Bell Investment Advisors, Inc transactions in Vericel Corp stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 82 shares of VCEL stock, worth $4,799. This represents 0.0% of its overall portfolio holdings.

Number of Shares
82
Previous 82 -0.0%
Holding current value
$4,799
Previous $3,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$30.85 - $37.09 $2,005 - $2,410
65 Added 382.35%
82 $2,000
Q2 2023

Aug 09, 2023

SELL
$29.0 - $38.37 $464 - $613
-16 Reduced 48.48%
17 $0
Q1 2023

May 10, 2023

BUY
$23.85 - $31.34 $119 - $156
5 Added 17.86%
33 $0
Q4 2022

Feb 08, 2023

BUY
$17.65 - $27.37 $494 - $766
28 New
28 $0
Q2 2022

Aug 12, 2022

BUY
$22.88 - $39.45 $434 - $749
19 New
19 $0

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.76B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Bell Investment Advisors, Inc Portfolio

Follow Bell Investment Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bell Investment Advisors, Inc with notifications on news.